First Time Loading...

Grifols SA
NASDAQ:GRFS

Watchlist Manager
Grifols SA Logo
Grifols SA
NASDAQ:GRFS
Watchlist
Price: 6.41 USD -1.99%
Updated: Apr 19, 2024

Intrinsic Value

Grifols SA engages in the production of plasma derivatives. [ Read More ]

The intrinsic value of one GRFS stock under the Base Case scenario is 24.32 USD. Compared to the current market price of 6.41 USD, Grifols SA is Undervalued by 74%.

Key Points:
GRFS Intrinsic Value
Base Case
24.32 USD
Undervaluation 74%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Grifols SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling GRFS stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Grifols SA

Provide an overview of the primary business activities
of Grifols SA.

What unique competitive advantages
does Grifols SA hold over its rivals?

What risks and challenges
does Grifols SA face in the near future?

Summarize the latest earnings call
of Grifols SA.

What significant events have occurred
in Grifols SA over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Grifols SA.

Provide P/S
for Grifols SA.

Provide P/E
for Grifols SA.

Provide P/OCF
for Grifols SA.

Provide P/FCFE
for Grifols SA.

Provide P/B
for Grifols SA.

Provide EV/S
for Grifols SA.

Provide EV/GP
for Grifols SA.

Provide EV/EBITDA
for Grifols SA.

Provide EV/EBIT
for Grifols SA.

Provide EV/OCF
for Grifols SA.

Provide EV/FCFF
for Grifols SA.

Provide EV/IC
for Grifols SA.

Show me price targets
for Grifols SA made by professional analysts.

What are the Revenue projections
for Grifols SA?

How accurate were the past Revenue estimates
for Grifols SA?

What are the Net Income projections
for Grifols SA?

How accurate were the past Net Income estimates
for Grifols SA?

What are the EPS projections
for Grifols SA?

How accurate were the past EPS estimates
for Grifols SA?

What are the EBIT projections
for Grifols SA?

How accurate were the past EBIT estimates
for Grifols SA?

Compare the revenue forecasts
for Grifols SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Grifols SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Grifols SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Grifols SA compared to its peers.

Compare the P/E ratios
of Grifols SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Grifols SA with its peers.

Analyze the financial leverage
of Grifols SA compared to its main competitors.

Show all profitability ratios
for Grifols SA.

Provide ROE
for Grifols SA.

Provide ROA
for Grifols SA.

Provide ROIC
for Grifols SA.

Provide ROCE
for Grifols SA.

Provide Gross Margin
for Grifols SA.

Provide Operating Margin
for Grifols SA.

Provide Net Margin
for Grifols SA.

Provide FCF Margin
for Grifols SA.

Show all solvency ratios
for Grifols SA.

Provide D/E Ratio
for Grifols SA.

Provide D/A Ratio
for Grifols SA.

Provide Interest Coverage Ratio
for Grifols SA.

Provide Altman Z-Score Ratio
for Grifols SA.

Provide Quick Ratio
for Grifols SA.

Provide Current Ratio
for Grifols SA.

Provide Cash Ratio
for Grifols SA.

What is the historical Revenue growth
over the last 5 years for Grifols SA?

What is the historical Net Income growth
over the last 5 years for Grifols SA?

What is the current Free Cash Flow
of Grifols SA?

Financials

Balance Sheet Decomposition
Grifols SA

Current Assets 6.5B
Cash & Short-Term Investments 669.8m
Receivables 815m
Other Current Assets 5B
Non-Current Assets 15B
Long-Term Investments 711.6m
PP&E 4.2B
Intangibles 9.6B
Other Non-Current Assets 450.8m
Current Liabilities 2.3B
Accounts Payable 813.1m
Other Current Liabilities 1.5B
Non-Current Liabilities 13.3B
Long-Term Debt 9.2B
Other Non-Current Liabilities 4.1B
Efficiency

Earnings Waterfall
Grifols SA

Revenue
6.6B EUR
Cost of Revenue
-4.1B EUR
Gross Profit
2.5B EUR
Operating Expenses
-1.8B EUR
Operating Income
735.7m EUR
Other Expenses
-676.3m EUR
Net Income
59.3m EUR

Free Cash Flow Analysis
Grifols SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

GRFS Profitability Score
Profitability Due Diligence

Grifols SA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
49/100
Profitability
Score

Grifols SA's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

GRFS Solvency Score
Solvency Due Diligence

Grifols SA's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Average D/E
Low Altman Z-Score
32/100
Solvency
Score

Grifols SA's solvency score is 32/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

GRFS Price Targets Summary
Grifols SA

Wall Street analysts forecast GRFS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GRFS is 14.69 USD with a low forecast of 5.66 USD and a high forecast of 23.39 USD.

Lowest
Price Target
5.66 USD
12% Downside
Average
Price Target
14.69 USD
129% Upside
Highest
Price Target
23.39 USD
265% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

GRF Price
Grifols SA

1M 1M
+7%
6M 6M
-23%
1Y 1Y
-12%
3Y 3Y
-64%
5Y 5Y
-65%
10Y 10Y
-52%
Annual Price Range
8.298
52w Low
6.898
52w High
15.455
Price Metrics
Average Annual Return -13.37%
Standard Deviation of Annual Returns 30.95%
Max Drawdown -79%
Shares Statistics
Market Capitalization 5.6B EUR
Shares Outstanding 678 410 694
Percentage of Shares Shorted
N/A

GRF Return Decomposition
Main factors of price return

What is price return decomposition?

GRFS News

Last Important Events
Grifols SA

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Grifols SA

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Grifols SA Logo
Grifols SA

Country

Spain

Industry

Biotechnology

Market Cap

5.6B USD

Dividend Yield

0%

Description

Grifols SA engages in the production of plasma derivatives. The company is headquartered in Barcelona, Barcelona and currently employs 23,233 full-time employees. The company went IPO on 2006-05-17. The company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.

Contact

BARCELONA
Barcelona
C/ Jesus y Maria, 6
+34935710000.0
http://www.grifols.com/es/web/international/home

IPO

2006-05-17

Employees

23 233

Officers

CEO & Executive Chairman
Mr. Thomas H. Glanzmann
CFO & VP
Mr. Alfredo Arroyo Guerra
Corporate Vice President and Director of Scientific & Medical Affairs
Mrs. Eva Bastida Tubau
VP of Corporate Treasury, Risk Management Investor Relation & Sustainability Officer
Ms. Nuria Pascual Lapeña
Chief Corporate Development, Legal & Data Protection Officer
Mr. David Ian Bell
Chief Communications Officer
Ms. Maria Teresa-Rioné Llano
Show More
Chief Human Resources Officer
Ms. Montserrat Gaja Llamas
Chief Quality Officer
Mr. Vicente Blanquer Torre
President of the Bio Supplies Division
Mr. Alberto Grifols Roura
President of Commercial Tech Support
Mr. Sergio Roura Adell
Show Less

See Also

Discover More
What is the Intrinsic Value of one GRFS stock?

The intrinsic value of one GRFS stock under the Base Case scenario is 24.32 USD.

Is GRFS stock undervalued or overvalued?

Compared to the current market price of 6.41 USD, Grifols SA is Undervalued by 74%.